Medipee

What Medipee does

Medipee GmbH is a German medical-technology company founded in 2017 in Moers, North Rhine-Westphalia, that has developed a contactless, automated urine analysis platform. The core product is an apple-sized device that attaches externally to a standard toilet and, upon detecting urine flow, extends a wire-mounted test strip into the bowl to perform measurement within seconds. Results are transmitted via Bluetooth Low Energy to a paired smartphone, tablet, or computer, where proprietary algorithms analyze fourteen standard urine parameters — including specific gravity, pH, leukocytes, nitrite, protein, glucose, ketones, urobilinogen, bilirubin, blood, ascorbic acid, microalbumin, and creatinine — and contextualize them against the user's longitudinal data. The platform is paired with two companion applications: Mikta, a digital fluid intake and micturition diary, and Uroli, the connected analytics app for the device.

The company addresses two primary customer segments. On the institutional side, Medipee sells to nursing homes, clinics, and hospitals seeking to replace manual cup-based sampling with hygienic, automated monitoring for elderly and chronic-care patients. On the consumer side, the Mikta and Uroli apps are available directly to health-conscious individuals, patients with diabetes, kidney disease or urinary stones, pregnant women, and athletes for preventive monitoring. The business model combines hardware device sales with recurring software/app subscriptions and — once approved — a Digital Health Application (DiGA) pathway under the German Digitale-Versorgung-Gesetz that enables physician prescription and statutory health-insurance reimbursement. Distribution is multi-channel: direct B2B field sales to healthcare institutions, physician and specialist networks (urology, gynecology), international trade fair presence (Medica Düsseldorf, DGU Congress, FOKO), and self-serve app distribution.

Medipee holds EN ISO 13485 certification for medical device quality (since March 2020) and ISO/IEC 27001:2017 (recertified October 2024). Funding to date includes a €1.44M INTERREG VA grant in February 2019 for the DigiPee cross-border project and a Series A round in April 2021 that included Geberit and Mücke Roth & Company as strategic investors. The company has won the Digipro-Award for best German-Dutch cross-border cooperation (2021) and placed third at the Witten Prize for Health Visionaries (2021). In February 2026, Jason Wi was appointed CEO to drive global operational scaling, marking a transition from founder-led development (Thomas Prokopp, Paul Bandi, Frank Willems) to commercial growth leadership.

Name

Medipee

Legal name

Medipee GmbH

Website

https://medipee.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Medipee GmbH is a German medical-technology company that builds a contactless, automated urine-analysis device attachable to standard toilets, paired with the Mikta and Uroli companion apps. It serves healthcare institutions (nursing homes, clinics, urology practices) and health-conscious consumers for preventive and chronic-condition monitoring.

Ownership category

akta.pro rank

Product category

Medical Devices (Automated Urine Diagnostics)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Urinalysis & Kidney Function POCT (Dipstick, Microalbumin, Creatinine) (HLAHAOAE)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Urology Telemedicine Platforms (HLALAGAN)

Keywords

• Contactless urine analysis
• Automated medical diagnostics
• Digital health devices
• Micturition tracking apps
• Point of care testing

Headquarters

HQ city

Moers

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Hardware Device Sales: Sale of the Medipee device - an apple-sized unit that attaches to standard toilets. The device includes the measurement mechanism with interchangeable test strip magazines.
2. Software/App Subscriptions: Companion smartphone apps (Mikta, Uroli) provide urine analysis results, micturition diaries, and health tracking. Likely subscription-based for premium features.
3. Digital Health Application (DiGA): Pursuing DiGA status under Germany's Digitale-Versorgung-Gesetz for urinary/kidney stone patient app, enabling health insurance reimbursement.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels11 records

Core offering

Medipee develops and sells a plug-and-play, contactless urine analysis platform. An apple-sized hardware device attaches to the outside of a standard toilet; an extendable wire arm positions a test strip into the urine stream upon automatic flow detection, measuring 14 standard parameters within seconds. Data is transmitted via Bluetooth Low Energy to the Uroli smartphone app for AI-based contextual analysis, supported by the Mikta micturition diary app, targeting both home users and professional healthcare settings (nursing homes, clinics, urology practices).

Product overview

Medipee offers a platform technology for automated, contactless urine analysis consisting of three main components: (1) the Medipee hardware device—an apple-sized unit attached to standard toilets that automatically performs urine measurements using test strips extended via a wire arm; (2) the Uroli app serving as the smart platform that receives and processes measurement data from the device; and (3) the Mikta app providing a digital drinking and micturition diary. The platform is designed for both home use and professional settings (nursing homes, clinics) and supports applications from preventive health monitoring to therapy outcome control. The system analyzes standard urine parameters (specific gravity, pH, leukocytes, nitrite, proteins, glucose, ketones, urobilinogen, bilirubin, blood, ascorbic acid, microalbumin, creatinine) and transmits data via Bluetooth Low Energy to smartphones, tablets, or computers.

Differentiator

Problem solved

Functional benefit

Brands

• Mikta: Digital fluid intake and micturition diary app for tracking drinking and urination patterns.
• Uroli

Products and services

• Medipee Automated Urine Analysis Device An apple-sized hardware device that attaches externally to a standard toilet. An extendable wire arm positions a test strip into the toilet bowl upon automatic detection of urine flow, completing measurement of 14 standard urine parameters within seconds. Data is transmitted via Bluetooth Low Energy to connected smartphones, tablets, or computers. Designed for both private household use and professional deployment in nursing homes and clinics, supporting applications from prophylaxis to therapy control.
• Uroli App Smart platform app that connects with the Medipee automated analysis device, receiving and processing urine measurement data for regular, contactless urine monitoring. Provides AI-based contextual health insights derived from 14 standard urine parameters, designed for individuals managing chronic conditions and for clinical decision support.
• Mikta App Smartphone app functioning as a digital drinking and micturition diary, enabling daily recording of fluid intake and urination patterns. Suitable for everyday lifestyle use and for medical-grade health monitoring, with potential as a Digital Health Application (DiGA) for kidney stone patients.

Quantifiable outcome

• 2 billion+ urine tests per year are often faulty, time-consuming, and unpleasant
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Universitätsklinik OldenburgcoreStrategic or Co-development PartnerConducted pilot study demonstrating positive care effects of Medipee app for kidney stone patients. Sufficient assumptions shown for positive care effects in urological application.
• SVDGV (Selbsthilfegruppe Deutsche Gesellschaft für Versorgung)minorGTM or Marketing PartnerListed as partner on Medipee website. Self-help group for supply management. Participated in Digitalversorgt-Tag event in Berlin.
• Kaasen MedizintechnikminorStrategic or Co-development PartnerMedical technology company with whom Medipee co-attended FOKO (gynecology training congress) to engage with gynecologists about applications.
• INTERREG Project Partners (German-Dutch)coreStrategic or Co-development PartnerMultiple German and Dutch companies in the border region participated in the EU-funded INTERREG Digipro project. Medipee collaborated closely with these partners over four years to develop the Medipee platform.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Scanwell Health: Scanwell Health offers at-home urine testing kits (notably for UTIs) analyzed via a smartphone app — a comparable business model that digitizes urinalysis for chronic and acute condition management outside the clinic.
• Vivoo: Vivoo provides at-home urine test strips paired with a smartphone app delivering wellness insights on hydration, pH, ketones and similar parameters — overlapping with Medipee's consumer-facing Mikta value proposition in the home wellness segment.

Broad incumbents

• Roche Diagnostics: Roche offers Chemstrip urinalysis strips and Urisys automated urine analyzers widely used in European clinics, representing the established professional urine-testing stack Medipee positions its platform against.
• Toto: Toto is a leading Japanese smart-toilet manufacturer whose premium Wellness Toilet concept integrates health-sensing features; represents the risk of integrated toilet incumbents absorbing toilet-attached diagnostics into their own products.
• Siemens Healthineers: Siemens Healthineers' CLINITEK family of urine chemistry analyzers is the dominant professional POC urinalysis platform in hospitals and clinics, the direct incumbent Medipee competes against in institutional deployments.
• Abbott: Abbott's Diagnostics division sells Multistix urinalysis strips and i-STAT analyzers used in professional settings, representing the incumbent diagnostic-strip-and-analyzer ecosystem that Medipee's B2B nursing-home and clinic channel must displace.
• Kohler: Kohler's Numi smart toilet and Innate intelligent toilet lines offer health-and-wellness-oriented features; relevant as a broad incumbent in premium smart-toilets that could embed diagnostic capabilities directly.

Direct peers

• Withings: Withings launched U-Scan, a cartridge-based chemical urine analysis system that sits inside the toilet bowl — the closest direct competitor to Medipee's plug-and-play contactless toilet urine analyzer, targeting overlapping home health-monitoring consumers in Europe.
• Healthy.io: Healthy.io offers smartphone-camera-based at-home urinalysis (e.g., Minuteful Kidney for ACR) and is reimbursed in several health systems, making it the most comparable direct competitor in digital at-home urine testing and a potential DiGA-channel rival.

Others

• Geberit: Geberit is a strategic investor in Medipee (2021 round) and the European leader in sanitary installation technology; comparable as a channel and ecosystem participant that could enable OEM or co-distribution of Medipee devices across European sanitary installations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/medipee_com
• Facebookfacebook.com/medipee
• LinkedInlinkedin.com/company/42904780
• Instagraminstagram.com/medipee

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medipee